SpotDraft, an AI-driven contract lifecycle management (CLM) platform for in-house legal teams, raised $54 million in Series B funding led by Vert ...

Some of the categories provided by the two entities include: commercial permits, business permits, building permits, commercial certificates of occupancy, as well as abstracts of judgment, state and ...

Trump's upcoming tariffs has the potential to bring biopharma manufacturing to the US, which could impact companies with ...

Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Listed 4iG group and space engineering company REMRED topped out a space technology manufacturing centre in Martonvásár, on ...

Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

Others who participated in the funding round were Vertex Ventures SEA, Sattva Family Office, Mirabilis Investment Trust, ...